Maruzen, S.; Munesue, S.; Okazaki, M.; Takada, S.; Nakanuma, S.; Makino, I.; Gong, L.; Kohno, S.; Takahashi, C.; Tajima, H.;
et al. Inhibitory Effects of Metformin for Pancreatic Neuroendocrine Neoplasms: Experimental Study on Mitochondrial Function. Onco 2024, 4, 77-86.
https://doi.org/10.3390/onco4020007
AMA Style
Maruzen S, Munesue S, Okazaki M, Takada S, Nakanuma S, Makino I, Gong L, Kohno S, Takahashi C, Tajima H,
et al. Inhibitory Effects of Metformin for Pancreatic Neuroendocrine Neoplasms: Experimental Study on Mitochondrial Function. Onco. 2024; 4(2):77-86.
https://doi.org/10.3390/onco4020007
Chicago/Turabian Style
Maruzen, Shogo, Seiichi Munesue, Mitsuyoshi Okazaki, Satoshi Takada, Shinichi Nakanuma, Isamu Makino, Linxiang Gong, Susumu Kohno, Chiaki Takahashi, Hidehiro Tajima,
and et al. 2024. "Inhibitory Effects of Metformin for Pancreatic Neuroendocrine Neoplasms: Experimental Study on Mitochondrial Function" Onco 4, no. 2: 77-86.
https://doi.org/10.3390/onco4020007
APA Style
Maruzen, S., Munesue, S., Okazaki, M., Takada, S., Nakanuma, S., Makino, I., Gong, L., Kohno, S., Takahashi, C., Tajima, H., Yamamoto, Y., & Yagi, S.
(2024). Inhibitory Effects of Metformin for Pancreatic Neuroendocrine Neoplasms: Experimental Study on Mitochondrial Function. Onco, 4(2), 77-86.
https://doi.org/10.3390/onco4020007
